F
Fulcrum Therapeutics D
D
FULC
6.81000
USD
0.22
(3.26%)
مغلق
حجم التداول
15,048
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
368,363,714
الأخبار المقالات
العنوان: Fulcrum Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.